CTIBIOTECH are leading a new path towards personalized cancer therapies through utilization of CELLINK’s technology platform. By taking a small piece of a patient’s tumor, multiplying the cells, and then bioprinting the patient’s tumor in the laboratory, researchers can discover, understand and find the exact treatment best for the specific cancer. CTIBIOTECH uses 3D bioprinting […]

CELLINK is happy to announce the CELLINK 3D Bioprinting Award for students and young scientists who present innovative 3D Bioprinting solutions at the 2017 TERMIS-AM conference in Charlotte, NC, USA. The award will be provided to a student or young investigator that is presenting his/her work based on an innovative 3D Bioprinting solution.  Representatives from […]